| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/MOL.0B013E3283347EBB |
| P698 | PubMed publication ID | 19915460 |
| P2093 | author name string | Giovanni Musso | |
| Maurizio Cassader | |||
| Roberto Gambino | |||
| P433 | issue | 1 | |
| P304 | page(s) | 76-83 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Current Opinion in Lipidology | Q15758705 |
| P1476 | title | Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders | |
| P478 | volume | 21 |
| Q24624433 | Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future? |
| Q28295293 | Acne vulgaris, probiotics and the gut-brain-skin axis: from anecdote to translational medicine |
| Q42682689 | Atopic dermatitis and the intestinal microbiota in humans and dogs |
| Q34733841 | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis |
| Q58596177 | Cannabis Therapeutics and the Future of Neurology |
| Q34462482 | Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis |
| Q45739447 | Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. |
| Q33451276 | Chicory inulin does not increase stool weight or speed up intestinal transit time in healthy male subjects |
| Q35015022 | Childhood obesity: a role for gut microbiota? |
| Q64108496 | Comparison of the fecal microbiota of two free-ranging Chinese subspecies of the leopard (Panthera pardus) using high-throughput sequencing |
| Q34035372 | Contribution of gut bacteria to liver pathobiology |
| Q37992743 | Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity |
| Q34961257 | Docosahexaenoic acid, inflammation, and bacterial dysbiosis in relation to periodontal disease, inflammatory bowel disease, and the metabolic syndrome |
| Q35124584 | Early life events influence whole-of-life metabolic health via gut microflora and gut permeability |
| Q37411378 | Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial |
| Q35949175 | Effects of Direct-fed Microbial and Pine Cone Extract on Carcass Traits and Meat Quality of Hanwoo (Korean Native Cattle). |
| Q35145256 | Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity |
| Q51322171 | Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. |
| Q28385595 | Epigenomic programing: a future way to health? |
| Q35857740 | Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training. |
| Q97093689 | Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children |
| Q37878883 | Fatty acid binding receptors in intestinal physiology and pathophysiology |
| Q27014809 | Fiber and prebiotics: mechanisms and health benefits |
| Q36413703 | Focus on therapeutic strategies of nonalcoholic Fatty liver disease |
| Q36327956 | Free fatty acid receptors: emerging targets for treatment of diabetes and its complications |
| Q34437446 | Gut bacterial profile in patients newly diagnosed with treatment-naïve Crohn's disease. |
| Q34866320 | Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. |
| Q35860576 | Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol |
| Q34899441 | Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? |
| Q34507490 | Human serum proteome analysis: new source of markers in metabolic disorders. |
| Q36597604 | ILSI Brazil International Workshop on Functional Foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and health |
| Q34269210 | Impact of the resident microbiota on the nutritional phenotype of Drosophila melanogaster |
| Q92714225 | Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease |
| Q36047143 | Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients |
| Q30353335 | Metagenome and metabolism: the tissue microbiota hypothesis. |
| Q36798196 | Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease |
| Q46380108 | Microbiota, NASH, HCC and the potential role of probiotics |
| Q35114851 | Modulation of gut microbiota in the management of metabolic disorders: the prospects and challenges |
| Q36166169 | Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. |
| Q42406740 | Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic |
| Q39180593 | Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet. |
| Q90544836 | Obesity-Related Asthma: Immune Regulation and Potential Targeted Therapies |
| Q34648009 | Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. |
| Q34111383 | Our unindicted coconspirators: human metabolism from a microbial perspective |
| Q38370919 | Paediatric non-alcoholic fatty liver disease: an overview |
| Q33563887 | Pediatric non-alcoholic fatty liver disease: New insights and future directions |
| Q37976341 | Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. |
| Q58566471 | Pharmaceutical Impact of and Metformin Combination on High-Fat-Diet-Induced Metabolic Disorders: Link to Intestinal Microbiota and Metabolic Endotoxemia |
| Q57803934 | Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease |
| Q34255464 | Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome |
| Q36228033 | Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD |
| Q34731373 | Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. |
| Q90040621 | Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding-A Review of Rodent Models |
| Q60950225 | Resveratrol-Induced White Adipose Tissue Browning in Obese Mice by Remodeling Fecal Microbiota |
| Q26801649 | Role of gut microbiota in the modulation of atherosclerosis-associated immune response |
| Q38231064 | Shared symptoms and putative biological mechanisms in chronic liver disease: implications for biobehavioral research |
| Q90231878 | Smallanthus sonchifolius (Yacon) Flour Improves Visceral Adiposity and Metabolic Parameters in High-Fat-Diet-Fed Rats |
| Q34627630 | Stool phospholipid signature is altered by diet and tumors |
| Q42085528 | THE IMPACT OF THE USE OF SYMBIOTICS IN THE PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE IN A RAT MODEL. |
| Q38548027 | Targeting fatty acid metabolism to improve glucose metabolism. |
| Q35759448 | Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence |
| Q28276657 | The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease |
| Q36165051 | The effects of symbiotic therapy on anthropometric measures, body composition and blood pressure in patient with metabolic syndrome: a triple blind RCT. |
| Q37973510 | The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance |
| Q27028844 | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions |
| Q60952879 | Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals |
| Q35691271 | Transforming berberine into its intestine-absorbable form by the gut microbiota |
| Q26752583 | Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight |
| Q46627885 | Weight status and dietary intake determine serum leptin concentrations in pregnant and lactating women and their infants |
Search more.